|
Volumn 62, Issue 18, 2002, Pages 5139-5143
|
Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARGINYLGLYCYLASPARTIC ACID;
CYTOTOXIC AGENT;
ISOPENTANE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BREAST CANCER;
CANCER CELL;
CANCER THERAPY;
CONTROLLED STUDY;
ENDOTHELIUM CELL;
FEMALE;
FLUORESCENCE ACTIVATED CELL SORTING;
FREEZING;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN TARGETING;
TUMOR CELL;
TUMOR VASCULARIZATION;
TUMOR XENOGRAFT;
ANIMALS;
BREAST NEOPLASMS;
ENDOTHELIUM, VASCULAR;
FEMALE;
FLOW CYTOMETRY;
FLUORESCEIN-5-ISOTHIOCYANATE;
FLUORESCENT DYES;
HUMANS;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
OLIGOPEPTIDES;
PROTEIN BINDING;
TRANSPLANTATION, HETEROLOGOUS;
TUMOR CELLS, CULTURED;
|
EID: 0037105767
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (276)
|
References (26)
|